Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
35.33
+0.15 (0.43%)
May 7, 2025, 4:00 PM EDT - Market closed
Xenon Pharmaceuticals Employees
As of December 31, 2024, Xenon Pharmaceuticals had 327 total employees, including 316 full-time and 11 part-time employees. The number of employees increased by 68 or 26.25% compared to the previous year.
Employees
327
Change (1Y)
68
Growth (1Y)
26.25%
Revenue / Employee
n/a
Profits / Employee
-$716,606
Market Cap
2.70B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
XENE News
- 2 days ago - Xenon to Report Q1 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 5 days ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Xenon- A Later Stage Story - Seeking Alpha
- 4 weeks ago - Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data - Seeking Alpha
- 4 weeks ago - Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025 - GlobeNewsWire
- 2 months ago - Xenon to Present at Stifel 2025 Virtual CNS Forum - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals Inc. (XENE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update - GlobeNewsWire